NCT00540293
Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study
See it on ClinicalTrials.gov ↗425 people
45.9%
54.1%
195 womenmiddle line = equal numbers230 men
- Phase
- PHASE4
- Paid for by
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Finished
- 2008-05
- Health conditions
- Dyslipidemias
- Who could join
- Anyone
- Ages
- 18 Years – 80 Years
- Average age
- mean 62.9 Years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“Is pregnant or lactating”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Is pregnant or lactating”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“…ocedure within the 3 months prior to screening that is likely to jeopardize the planned termination of the study. (e.g., any carcinoma, coronary angioplasty, coronary artery bypass graft, cardiac infarct, severe or unstable angina pectoris)”
- No cancer
Women with current or past cancer were turned away.
“…ocedure within the 3 months prior to screening that is likely to jeopardize the planned termination of the study. (e.g., any carcinoma, coronary angioplasty, coronary artery bypass graft, cardiac infarct, severe or unstable angina pectoris)”
Study titles and rules are shown in their original English.